HONG KONG (Reuters/IFR) – Chinese biotech Ascletis Pharma Inc (1672.HK) raised $400 million after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong Kong l…
( read original story …)
The HongKong News
HONG KONG (Reuters/IFR) – Chinese biotech Ascletis Pharma Inc (1672.HK) raised $400 million after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong Kong l…
( read original story …)